STALEY CAPITAL ADVISERS’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
TS
IAM
MVP
STALEY CAPITAL ADVISERS's PGEN Position: Q3 2018 in Review
STALEY CAPITAL ADVISERS sold out of Precigen (PGEN) in Q3 2018, closing a stake of 40,000 shares — an estimated $558K sold.
STALEY CAPITAL ADVISERS first reported a position in PGEN in Q4 2014 and held it in 6 quarters. The position peaked at $613K in Q1 2018. 170 funds tracked by Wall St. Rank hold PGEN as of Q3 2018.
- STALEY CAPITAL ADVISERS reported no remaining Precigen position as of Q3 2018 after selling out during the quarter.
- STALEY CAPITAL ADVISERS sold 40,000 Precigen shares in Q3 2018, an estimated $558K.
- STALEY CAPITAL ADVISERS first reported a position in Precigen in Q4 2014 and held it in 6 quarters.
- STALEY CAPITAL ADVISERS's Precigen position peaked at $613K in Q1 2018.
- 170 funds tracked by Wall St. Rank held Precigen as of Q3 2018.
Based on STALEY CAPITAL ADVISERS's 13F filing for Q3 2018, filed 9 Nov 2018.